Publicaciones en las que colabora con Mariano Valdés Chávarri (24)

2019

  1. Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome

    European Journal of Internal Medicine, Vol. 61, pp. 48-53

2018

  1. Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA 2 DS 2 -VASc and HAS-BLED scores using multiple biomarkers

    Annals of Medicine, Vol. 50, Núm. 1, pp. 26-34

  2. A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials

    Mayo Clinic Proceedings, Vol. 93, Núm. 8, pp. 1065-1073

  3. Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality

    International Journal of Clinical Practice, Vol. 72, Núm. 3

  4. Bleeding risk prediction in patients with dual antiplatelet therapy undergoing coronary artery bypass grafting surgery using a rapid point-of-care platelet function test

    Circulation: Cardiovascular Interventions, Vol. 11, Núm. 12

  5. Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines

    PLoS ONE, Vol. 13, Núm. 11

  6. Disparities in the estimation of glomerular filtration rate according to cockcroft-gault, modification of diet in renal disease-4, and chronic kidney disease epidemiology collaboration equations and relation with outcomes in patients with acute coronary syndrome

    Journal of the American Heart Association, Vol. 7, Núm. 9

  7. Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in ‘real-world’ atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients

    International Journal of Cardiology, Vol. 254, pp. 125-131

  8. Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation

    European Journal of Clinical Investigation, Vol. 48, Núm. 6

  9. Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA2DS2-VASc and HAS-BLED

    American Heart Journal, Vol. 197, pp. 27-34

  10. Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol

    Clinical Therapeutics, Vol. 40, Núm. 1, pp. 114-122

  11. Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project

    Journal of General Internal Medicine, Vol. 33, Núm. 6, pp. 847-854

  12. Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 23, Núm. 1, pp. 57-65

  13. Temporal changes in platelet response in acute coronary syndrome patients with prasugrel and clopidogrel after stent implantation

    Circulation Journal, Vol. 82, Núm. 2, pp. 353-360

2017

  1. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

    Thrombosis and Haemostasis, Vol. 117, Núm. 7, pp. 1448-1454

  2. Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

    Scientific Reports, Vol. 7

  3. Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation

    Scientific Reports, Vol. 7, Núm. 1

  4. Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and abc-bleeding risk scores: The murcia atrial fibrillation project

    Thrombosis and Haemostasis, Vol. 117, Núm. 10, pp. 1848-1858

  5. Long-term stroke risk prediction in patients with atrial fibrillation: Comparison of the ABC-stroke and CHA2DS2-VASc scores

    Journal of the American Heart Association, Vol. 6, Núm. 7

  6. Low body weight and clinical outcomes in acute coronary syndrome patients: results of the ACHILLES Registry

    European Journal of Cardiovascular Nursing, Vol. 16, Núm. 8, pp. 696-703